tirzepatide peptide compound 10mg — GLP-1/GIP Dual-Agonist Research Tirzepatide / Niacinamide Injection |

Why Brand-Name Cant Match Price Structural Barriers: Public Company Obligations: Must maximize shareholder return Quarterly earnings pressure Executive compensation tied to profits Cant dramatically reduce price without stock impact Sunk Costs: Billions invested in development Need to recoup investment Justify to shareholders and board Complex Distribution System: PBMs demand rebates Wholesalers take cut Pharmacy margins Cant easily change system Market Dynamics: Limited competition (patent protection) Can charge premium prices Demand exceeds supply No pressure to reduce Eli Lilly unlikely to reduce tirzepatide prices significantly while patents protected

direct-to-consumer healthcare experience

This is why you should always keep a record of your progress and share it with your doctor, who can make personalized adjustments to your treatment plan

Both brands are a pproved to be used to support the weight loss journey of an individual

Learn more or schedule your appointment today.

That is true whether a medication got her there or willpower did